Additional risk minimization materials

Non-promotional HCPs/patients educational materials are required as additional risk-minimizing measures to ensure that healthcare professionals who prescribe and use these medicines, as well as patients, are aware of and take into account the specific safety requirements. The educational materials complement the information in the Singapore package insert.

Accessing educational materials


All materials are available in digital format and can be downloaded by clicking on 'Download PDF'. Should you require physical copies, please contact us.

camzyos HCP Guide 2025

Camzyos® (mavacamten) Healthcare Professionals Guide


Intended for use by healthcare professionals in conjunction with the approved Singapore package insert.

Download PDF

Camzyos patient guide 2025

Camzyos® (mavacamten) Patient Guide


Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.
 

Download PDF

camzyos patient card 2025

Camzyos® (mavacamten) Patient Card
 

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.


Download PDF

opdivo nivolumab Patient Alert Card

Opdivo® (nivolumab) Patient Card
 

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.
 

Download PDF

Opdualag english

Opdualag® (nivolumab and relatlimab for injection) Patient Card English
 

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.
 

Download PDF

Opdualag chinese

Opdualag® (nivolumab and relatlimab for injection) Patient Card Chinese
 

Intended for dissimination by healthcare professionals to their patients or patients' caregivers.
 

Download PDF

cover image

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Acknowledgement Form
 

Intended for use by healthcare professionals in conjunction with the approved Singapore package insert.


Download PDF

Cover image

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Cover letter
 

Intended for use by healthcare professionals in conjunction with the approved Singapore package insert.

Download PDF

Camzyos patient guide 2025

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Risk Awareness Form
 

Intended for use by healthcare professionals in conjunction with the approved Singapore package insert.


Download PDF

Pomalys Revlimid Healthcare Professionals Brochure

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Brochure
 

Intended for use by healthcare professionals in conjunction with the approved Singapore package insert.

Download PDF

cover image

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Agreement Form
 

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.


Download PDF

cover image

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Medication Guide
 

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.


Download PDF

cover image

Yervoy® (ipilimumab) Patient Card
 

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.
 

Download PDF